Study Suggests Some RA Patients at Increased Risk for Actemra Infections

A new study published in the scientific journal Rheumatology indicates that certain patients with rheumatoid arthritis (RA) who take Actemra (tocilizumab) to treat their symptoms may be at an increased risk for dangerous infections than others. Actemra, manufactured by Roche and subsidiary Genentech, is a drug that works by inhibiting parts of the immune system… read more